Trials review: Cardiovascular outcome with intensive glycemic control and implications for patients with type 2 diabetes

Postgraduate Medicine

Volumn 121, Issue 5, 2009, Pages 31-41

  Brown, Siobhan H M ^a   Abdelhafiz, Ahmed H ^a  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Diverse patient populations; Intensive glycemic control

Indexed keywords

HEMOGLOBIN A1C; INSULIN; PHENFORMIN; PLACEBO; SULFONYLUREA; TOLBUTAMIDE;

BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DIABETIC PATIENT; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; REVIEW;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAUSALITY; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; TOLBUTAMIDE; VASCULAR DISEASES; YOUNG ADULT;

EID: 78649312216     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.09.2050     Document Type: Review

References (31)

1. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421-431.
2. DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care. 2003;26(3):688-696.
3. Teuscher AU, Reinli K, Teuscher A. Prevalence of diabetes mellitus and impaired glucose in elderly European subjects. Diabetes. 1999;(48 suppl 1):395-396.
4. Lindeman RD, Romero LJ, Hundley R, et al. Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly biethnic population. Diabetes Care. 1998;21(6):959-966. (Pubitemid 28488788)
5. Chin MH, Zhang JX, Merrel K. Speciality differences in the care of older patients with diabetes. Med Care. 2000;38(2):131-140.
6. Abrahamson MJ. A 74-year-old woman with diabetes. JAMA. 2007;297(2):196-204.
7. Hayward RA, Hofer TP, Vijan S. Intensive glucose control in elderly adults. JAMA. 2007;297(20):2195.
8. University Group Diabetes Program. I; design and baseline results methods. Diabetes. 1970;19(suppl 2):747-783.
9. Meinert CL, Knatteraud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular completions in patients with adult-onset diabetes. II. Mortality results. Diabetes. 1970;19(suppl):789-830.
10. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. Diabetes. 1982;31(suppl 5):1-81.
11. Ohkubo Y, Kishikawa H, Araki E, etal. Intensive insulin therapy prevents the progression of diabetic microvasular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103-117.
12. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(suppl 2):B21-B29.
13. Abraira C, Colwell J, Nuttall F, et al. Cardiovascular events and correlates in the Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intent Med. 1997;157(2):181-188.
14. Duckworth W, Abraira C, Moritz T, et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-139.
15. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications inpatients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-853.
16. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854-865. (Pubitemid 28416719)
17. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999;353(9153):617-622.
18. ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572.
19. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559.
20. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589.
21. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial mtervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383-393. (Pubitemid 36159355)
22. Gaede P, Lund-Anderson H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580-591. (Pubitemid 351214285)
23. Nathan DM, Cleary PA, Backlund JY, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643-2653.
24. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977-986.
25. Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765- 1772.
26. Blaum CS, Volpato S, Cappola AR, et al. Diabetes, hyperglycaemia and mortality in disabled older women: The Women's Health and Ageing Study I. Diabet Med. 2005;22(5):543-550. (Pubitemid 40593128)
27. Schwartz AV, Vittinghoff E, Sellmeyer DE, et al; Health, Aging, and Body Composition Study. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care. 2008;31(3):391-396.
28. Pham M, Pinganaud G, Richard-Harston S, Decamps A, Bourdel-Marchasson I. Prospective audit of diabetes care and outcomes in a group of geriatric French care homes. Diabetes Metab. 2003;29(3):251-258.
29. Cukierman-Yaffe T, Gerstein HC, Williamson JD, et al; Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care. 2009;32(2):221-226.
30. Abdelhafiz AH, Sinclair AJ. Hypoglycaemia in residential care homes. Br J Gen Pract. 2009;59(558):49-50.
31. Huang ES, Zhang Q, Gandra N, Chin MH, Meltzer DO. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med. 2008;149(1):11-19.